BERG Creates Collaborative Healthcare Model to Transform the Future of Drug Development.

Partners across multiple healthcare divisions join forces to break down siloes to accelerate precision medicine opportunities for COVID-19 and beyond BERG, a clinical-stage biotech that...

CureVac COVID-19 vaccine induces immune response in early trial.

German vaccine maker CureVac said that interim results from early trials showed that its investigational Covid-19 vaccine candidate...

Novartis, Molecular Partners team up to develop DARPin therapeutics for COVID-19.

Novartis and Molecular Partners announced a collaboration in the form of an option and license agreement to develop, manufacture...

Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S..

Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing...

Lonza Announces Agreement to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination.

Lonza announced that the company has signed an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting...

Lilly to Supply 300,000 Vials of Neutralizing Antibody Bamlanivimab in an Effort to Fight COVID-19.

Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab 700 mg, an investigational neutralizing antibody, for $375 million.

Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab.

Samsung Biologics and Checkpoint Therapeutics announced the expansion of a long-term manufacturing partnership for Checkpoint's anti...

Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy.

Acquisition fuels Bayer's cell and gene therapy platform with potential to bring urgently needed treatments to patients across multiple disease...